BioScience Health Innovations, Inc.
NOTR
$9.01
-$0.99-9.90%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 87.00K | 38.60K | -74.70K | -234.20K | -251.50K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -63.90K | -21.70K | -30.90K | -55.10K | -56.40K |
| Cash from Operations | 23.20K | 17.00K | -105.60K | -289.20K | -307.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -26.00K | -7.00K | -- | -- | -- |
| Cash from Investing | -26.00K | -7.00K | -- | -- | -- |
| Total Debt Issued | 962.80K | 949.50K | 851.80K | 773.00K | 613.90K |
| Total Debt Repaid | -1.07M | -993.30K | -952.70K | -840.50K | -572.40K |
| Issuance of Common Stock | 755.00K | 325.00K | 320.00K | 440.00K | 265.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | 8.80K |
| Cash from Financing | 646.10K | 281.20K | 219.10K | 372.60K | 315.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 643.30K | 291.20K | 113.60K | 83.50K | 7.70K |